Fingerprint
Dive into the research topics of 'Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically